1. Home
  2. MLEC vs TXMD Comparison

MLEC vs TXMD Comparison

Compare MLEC & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLEC
  • TXMD
  • Stock Information
  • Founded
  • MLEC 2008
  • TXMD 2008
  • Country
  • MLEC Cayman Islands
  • TXMD United States
  • Employees
  • MLEC N/A
  • TXMD N/A
  • Industry
  • MLEC Blank Checks
  • TXMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLEC Finance
  • TXMD Health Care
  • Exchange
  • MLEC Nasdaq
  • TXMD Nasdaq
  • Market Cap
  • MLEC 12.9M
  • TXMD 12.7M
  • IPO Year
  • MLEC N/A
  • TXMD N/A
  • Fundamental
  • Price
  • MLEC $1.19
  • TXMD $1.09
  • Analyst Decision
  • MLEC
  • TXMD
  • Analyst Count
  • MLEC 0
  • TXMD 0
  • Target Price
  • MLEC N/A
  • TXMD N/A
  • AVG Volume (30 Days)
  • MLEC 241.5K
  • TXMD 17.8K
  • Earning Date
  • MLEC 10-01-2025
  • TXMD 11-11-2025
  • Dividend Yield
  • MLEC N/A
  • TXMD N/A
  • EPS Growth
  • MLEC N/A
  • TXMD N/A
  • EPS
  • MLEC N/A
  • TXMD N/A
  • Revenue
  • MLEC N/A
  • TXMD $2,559,000.00
  • Revenue This Year
  • MLEC $20.42
  • TXMD $427.09
  • Revenue Next Year
  • MLEC $30.00
  • TXMD N/A
  • P/E Ratio
  • MLEC N/A
  • TXMD N/A
  • Revenue Growth
  • MLEC 170.36
  • TXMD 156.93
  • 52 Week Low
  • MLEC $1.10
  • TXMD $0.70
  • 52 Week High
  • MLEC $10.47
  • TXMD $2.44
  • Technical
  • Relative Strength Index (RSI)
  • MLEC 22.97
  • TXMD 47.46
  • Support Level
  • MLEC $1.10
  • TXMD $1.06
  • Resistance Level
  • MLEC $1.45
  • TXMD $1.14
  • Average True Range (ATR)
  • MLEC 0.11
  • TXMD 0.05
  • MACD
  • MLEC 0.10
  • TXMD -0.00
  • Stochastic Oscillator
  • MLEC 27.00
  • TXMD 20.95

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: